SII Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,349
Closed -$267K 204
2017
Q4
$267K Sell
3,349
-1,147
-26% -$91.9K 0.03% 328
2017
Q3
$351K Buy
4,496
+138
+3% +$11.5K 0.02% 442
2017
Q2
$387K Sell
4,358
-1,414
-24% -$119K 0.02% 400
2017
Q1
$464K Buy
5,772
+68
+1% +$5.31K 0.03% 351
2016
Q4
$407K Buy
5,704
+596
+12% +$46.8K 0.03% 366
2016
Q3
$442K Sell
5,108
-218
-4% -$19K 0.03% 341
2016
Q2
$462K Sell
5,326
-1,761
-25% -$142K 0.04% 325
2016
Q1
$536K Sell
7,087
-63
-0.9% -$4.75K 0.05% 291
2015
Q4
$550K Sell
7,150
-293
-4% -$22.1K 0.07% 232
2015
Q3
$501K Sell
7,443
-1,132
-13% -$83.4K 0.06% 289
2015
Q2
$631K Sell
8,575
-425
-5% -$32.5K 0.07% 246
2015
Q1
$707K Sell
9,000
-2,078
-19% -$157K 0.09% 215
2014
Q4
$793K Sell
11,078
-24
-0.2% -$1.67K 0.1% 189
2014
Q3
$680K Buy
11,102
+1,167
+12% +$74.2K 0.09% 213
2014
Q2
$633K Buy
9,935
+3,353
+51% +$204K 0.09% 222
2014
Q1
$367K Sell
6,582
-91
-1% -$5.3K 0.07% 275
2013
Q4
$384K Buy
6,673
+914
+16% +$51.8K 0.07% 281
2013
Q3
$307K Buy
5,759
+459
+9% +$24.7K 0.07% 246
2013
Q2
$272K Buy
+5,300
New +$262K 0.06% 296

Other funds holding MDT

SII Investments's MDT Position: Q1 2018 in Review

SII Investments sold out of Medtronic (MDT) in Q1 2018, closing a stake of 3,349 shares — an estimated $267K sold.

SII Investments first reported a position in MDT in Q2 2013 and held it in 19 quarters. The position peaked at $793K in Q4 2014. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • SII Investments reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 3,349 Medtronic shares in Q1 2018, an estimated $267K.
  • SII Investments first reported a position in Medtronic in Q2 2013 and held it in 19 quarters.
  • SII Investments's Medtronic position peaked at $793K in Q4 2014.
  • 1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.